Stay updated on DC-806 in Plaque Psoriasis Clinical Trial
Sign up to get notified when there's something new on the DC-806 in Plaque Psoriasis Clinical Trial page.

Latest updates to the DC-806 in Plaque Psoriasis Clinical Trial page
- Check2 days agoNo Change Detected
- Check9 days agoNo Change Detected
- Check16 days agoChange DetectedThe page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.SummaryDifference1%
- Check30 days agoNo Change Detected
- Check38 days agoChange DetectedThe web page now includes a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with contact information for assistance.SummaryDifference1%
- Check45 days agoChange DetectedThe website has been updated from version v2.14.1 to v2.14.2.SummaryDifference0.1%
- Check59 days agoChange DetectedThe website has been updated from version 2.14.0 to 2.14.1.SummaryDifference0.1%
- Check66 days agoChange DetectedThe website has updated the intervention type and added new dates for updates in 2025, while removing previous dates and an older revision.SummaryDifference1%
- Check96 days agoChange DetectedEli Lilly and Company has added new identifiers and dates related to DICE Therapeutics, while several previous identifiers and dates have been removed, indicating updates in their tracking or reporting.SummaryDifference2%
Stay in the know with updates to DC-806 in Plaque Psoriasis Clinical Trial
Enter your email address, and we'll notify you when there's something new on the DC-806 in Plaque Psoriasis Clinical Trial page.